TY  - JOUR 
AU  - Cuadrado-Tejedor, Mar
AU  - Pérez-González, Marta
AU  - García-Muñoz, Cristina
AU  - Muruzabal, Damián
AU  - Garcia-Barroso, Carolina
AU  - Rabal, Obdulia
AU  - Segura, Victor
AU  - Sánchez-Arias, Juan Antonio
AU  - Oyarzabal, Julen
AU  - Garcia-Osta, Ana
PY  - 2019
SN  - 1663-4365
UR  - http://hdl.handle.net/20.500.12020/1553
AB  - The discouraging results with therapies for Alzheimer's disease (AD) in clinical trials, highlights the urgent need to adopt new approaches. Like other complex diseases, it is becoming clear that AD therapies should focus on the simultaneous...
LA  - en
PB  - Frontiers Media
TI  - Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease
DO  - https://doi.org/10.3389/fnagi.2019.00149
T2  - Frontiers in Aging Neuroscience
M2  - 1
KW  - Alzheimer’s Disease
KW  - Multitarget Therapy
KW  - Histone Deacetylase
KW  - Phosphodiesterase
KW  - Memory
VL  - 11
ER  -